Long Term Pharmacy
Long Term Pharmacy
  • Partnering with Genoa

Partnering with Genoa Healthcare for Assisted Living Pharmacy: PeopleServe (Jackson, Wisc.)

Mar 1st, 2021

Josh McCutcheon, Team Coordinator, PeopleServe, describes how Genoa Healthcare has improved pharmacy care at PeopleServe.

PeopleServe provides home care, living arrangements and residential support to individuals with disabilities in Wisconsin. We started working with Genoa Healthcare to provide pharmacy services to our residents in 2012 and have yet to look back.

Unparalleled customer service

Above all else, Genoa Healthcare exemplifies an unheard of level of customer service. When we pick up the phone we always speak to a real person. Their consulting pharmacists are knowledgeable, professional, and they work seamlessly with our staff.

In fact, when we made the decision to transition to Genoa more than nine years ago, they did an outstanding job during the conversion. Whatever it takes to get the job done, they’re always in lock step with us through the entire process.

The meaning of integrity

We recently had a resident who had a relatively invasive emergency surgery and was potentially going to be hospitalized, which was something our resident didn’t want. Fortunately he was able to come home because we got a hold of Genoa and were able to get his medications after hours in a timely fashion. It was literally just one call to Genoa and we were able to prevent him from having to stay in the hospital overnight.

An integral part of our team

The level of attention, follow-up, and overall service of Genoa is unmatched. Their management is personally involved in the daily operations of their pharmacy teams and more importantly, their employees demonstrate a sense of ownership in their decisions and actions.

I’d recommend Genoa to any assisted living facility that is looking for a high-touch, approachable, and dependable pharmacy partner.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
4 things to know about Spravato® (Intranasal esketamine)

On January 21, 2025, the FDA announced the approval of Spravato® nasal spray as a monotherapy treatment for treatment-resistant depression (TRD), making this medication the first and only monotherapy option...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa’s 2024 Art Celebration: Celebrating the healing power of creativity

“I’ve always expressed myself through my art and learned to use my creativity to inspire others”, says Genoa Healthcare 2024 Art Celebration participant Shanelle G. Genoa’s annual Art Celebration invites...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Esketamine: Latest research offers new hope for adolescents with treatment-resistant depression

Adolescents with treatment-resistant depression (TRD) often struggle with a lack of effective treatment options. While ketamine has been shown to help improve outcomes for adults living with major depressive disorder...

  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...